{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:14:13Z","timestamp":1791825253633,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,15]]},"DOI":"10.7759\/cureus.45279","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T07:43:24Z","timestamp":1694763804000},"source":"Crossref","is-referenced-by-count":3,"title":["Digesting the Impact of Diet on Irritable Bowel Syndrome (IBS): Exploring Solutions for Controlling IBS"],"prefix":"10.7759","author":[{"given":"Sai Suseel","family":"Sarvepalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shree Laya","family":"Vemula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saikumar","family":"Aramadaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raam","family":"Mannam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajagopal","family":"Sankara Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpit","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishnu R","family":"Yanamaladoddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"The principles and practice of medicine","author":"Osler W","year":"1912","unstructured":"Osler W. The principles and practice of medicine. D. Appleton & Company, New York and London; 1912."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(97)05276-8","article-title":"Irritable bowel syndrome","volume":"350","author":"Maxwell PR","year":"1997","unstructured":"Maxwell PR, Mendall MA, Kumar D. Irritable bowel syndrome. Lancet. 1997, 350:1691-5. 10.1016\/s0140-6736(97)05276-8","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(80)90142-0","article-title":"Functional bowel disorders in apparently healthy people","volume":"79","author":"Thompson WG","year":"1980","unstructured":"Thompson WG, Heaton KW. Functional bowel disorders in apparently healthy people. Gastroenterology. 1980, 79:283-8. 10.1016\/0016-5085(80)90142-0","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis","volume":"10","author":"Lovell RM","year":"2012","unstructured":"Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012, 10:712-721.e4. 10.1016\/j.cgh.2012.02.029","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2010.12.013","article-title":"The effect of irritable bowel syndrome on health-related quality of life and health care expenditures","volume":"40","author":"Agarwal N","year":"2011","unstructured":"Agarwal N, Spiegel BM. The effect of irritable bowel syndrome on health-related quality of life and health care expenditures. Gastroenterol Clin North Am. 2011, 40:11-9. 10.1016\/j.gtc.2010.12.013","journal-title":"Gastroenterol Clin North Am"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-003-0073-z","article-title":"New insights into the psychosocial aspects of irritable bowel syndrome","volume":"5","author":"Lea R","year":"2003","unstructured":"Lea R, Whorwell PJ. New insights into the psychosocial aspects of irritable bowel syndrome. Curr Gastroenterol Rep. 2003, 5:343-50. 10.1007\/s11894-003-0073-z","journal-title":"Curr Gastroenterol Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2005.00744.x","article-title":"A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation","volume":"60","author":"Malagelada JR","year":"2006","unstructured":"Malagelada JR. A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation. Int J Clin Pract. 2006, 60:57-63. 10.1111\/j.1368-5031.2005.00744.x","journal-title":"Int J Clin Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i7.616","article-title":"Psychosocial determinants of irritable bowel syndrome","volume":"18","author":"Surdea-Blaga T","year":"2012","unstructured":"Surdea-Blaga T, B\u0103ban A, Dumitrascu DL. Psychosocial determinants of irritable bowel syndrome. World J Gastroenterol. 2012, 18:616-26. 10.3748\/wjg.v18.i7.616","journal-title":"World J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth GF","year":"2006","unstructured":"Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006, 130:1480-91. 10.1053\/j.gastro.2005.11.061","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","author":"Mearin F","year":"2016","unstructured":"Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel disorders. Gastroenterology. 2016, 10.1053\/j.gastro.2016.02.031","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.04.032","article-title":"Management options for irritable bowel syndrome","volume":"93","author":"Camilleri M","year":"2018","unstructured":"Camilleri M. Management options for irritable bowel syndrome. Mayo Clin Proc. 2018, 93:1858-72. 10.1016\/j.mayocp.2018.04.032","journal-title":"Mayo Clin Proc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000051878","article-title":"Food-related gastrointestinal symptoms in the irritable bowel syndrome","volume":"63","author":"Simr\u00e9n M","year":"2001","unstructured":"Simr\u00e9n M, M\u00e5nsson A, Langkilde AM, Svedlund J, Abrahamsson H, Bengtsson U, Bj\u00f6rnsson ES. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion. 2001, 63:108-15. 10.1159\/000051878","journal-title":"Digestion"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199805000-00011","article-title":"Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study","volume":"10","author":"Ragnarsson G","year":"1998","unstructured":"Ragnarsson G, Bodemar G. Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study. Eur J Gastroenterol Hepatol. 1998, 10:415-21. 10.1097\/00042737-199805000-00011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0270-3","article-title":"Evidence-based and mechanistic insights into exclusion diets for IBS","volume":"17","author":"Moayyedi P","year":"2020","unstructured":"Moayyedi P, Simr\u00e9n M, Bercik P. Evidence-based and mechanistic insights into exclusion diets for IBS. Nat Rev Gastroenterol Hepatol. 2020, 17:406-13. 10.1038\/s41575-020-0270-3","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0193-z","article-title":"Intestinal gases: influence on gut disorders and the role of dietary manipulations","volume":"16","author":"Kalantar-Zadeh K","year":"2019","unstructured":"Kalantar-Zadeh K, Berean KJ, Burgell RE, Muir JG, Gibson PR. Intestinal gases: influence on gut disorders and the role of dietary manipulations. Nat Rev Gastroenterol Hepatol. 2019, 16:733-47. 10.1038\/s41575-019-0193-z","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4166\/kjg.2022.014","article-title":"Efficacy of a restrictive diet in irritable bowel syndrome: a systematic review and network meta-analysis","volume":"80","author":"Yu SJ","year":"2022","unstructured":"Yu SJ, Lee HS, Gung HJ, et al.. Efficacy of a restrictive diet in irritable bowel syndrome: a systematic review and network meta-analysis. Korean J Gastroenterol. 2022, 80:6-16. 10.4166\/kjg.2022.014","journal-title":"Korean J Gastroenterol"},{"key":"ref17","article-title":"Carbohydrate malabsorption and the effect of dietary restriction on symptoms of irritable bowel syndrome and functional bowel complaints","volume":"2","author":"Goldstein R","year":"2000","unstructured":"Goldstein R, Braverman D, Stankiewicz H. Carbohydrate malabsorption and the effect of dietary restriction on symptoms of irritable bowel syndrome and functional bowel complaints. Isr Med Assoc J. 2000, 2:583-7.","journal-title":"Isr Med Assoc J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X11436241","article-title":"Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals?","volume":"5","author":"Barrett JS","year":"2012","unstructured":"Barrett JS, Gibson PR. Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals?. Therap Adv Gastroenterol. 2012, 5:261-8. 10.1177\/1756283X11436241","journal-title":"Therap Adv Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02506.x","article-title":"Personal view: food for thought--western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis","volume":"21","author":"Gibson PR","year":"2005","unstructured":"Gibson PR, Shepherd SJ. Personal view: food for thought--western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis. Aliment Pharmacol Ther. 2005, 21:1399-409. 10.1111\/j.1365-2036.2005.02506.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jada.2006.07.010","article-title":"Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management","volume":"106","author":"Shepherd SJ","year":"2006","unstructured":"Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc. 2006, 106:1631-9. 10.1016\/j.jada.2006.07.010","journal-title":"J Am Diet Assoc"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.02.058","article-title":"Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence","volume":"6","author":"Shepherd SJ","year":"2008","unstructured":"Shepherd SJ, Parker FC, Muir JG, Gibson PR. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol. 2008, 6:765-71. 10.1016\/j.cgh.2008.02.058","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04237.x","article-title":"Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon","volume":"31","author":"Barrett JS","year":"2010","unstructured":"Barrett JS, Gearry RB, Muir JG, et al.. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther. 2010, 31:874-82. 10.1111\/j.1365-2036.2010.04237.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06370.x","article-title":"Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome","volume":"25","author":"Ong DK","year":"2010","unstructured":"Ong DK, Mitchell SB, Barrett JS, et al.. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol. 2010, 25:1366-73. 10.1111\/j.1440-1746.2010.06370.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01072.x","article-title":"The degree of breath methane production in IBS correlates with the severity of constipation","volume":"102","author":"Chatterjee S","year":"2007","unstructured":"Chatterjee S, Park S, Low K, Kong Y, Pimentel M. The degree of breath methane production in IBS correlates with the severity of constipation. Am J Gastroenterol. 2007, 102:837-41. 10.1111\/j.1572-0241.2007.01072.x","journal-title":"Am J Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-199005000-00010","article-title":"Breath methane production in children with constipation and encopresis","volume":"10","author":"Fiedorek SC","year":"1990","unstructured":"Fiedorek SC, Pumphrey CL, Casteel HB. Breath methane production in children with constipation and encopresis. J Pediatr Gastroenterol Nutr. 1990, 10:473-7. 10.1097\/00005176-199005000-00010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-277X.2010.01139.x","article-title":"Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals","volume":"24","author":"Biesiekierski JR","year":"2011","unstructured":"Biesiekierski JR, Rosella O, Rose R, et al.. Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals. J Hum Nutr Diet. 2011, 24:154-76. 10.1111\/j.1365-277X.2010.01139.x","journal-title":"J Hum Nutr Diet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2672.2007.03520.x","article-title":"Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics","volume":"104","author":"Macfarlane GT","year":"2008","unstructured":"Macfarlane GT, Steed H, Macfarlane S. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol. 2008, 104:305-44. 10.1111\/j.1365-2672.2007.03520.x","journal-title":"J Appl Microbiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/00365529850172502","article-title":"Fructose-sorbitol malabsorption and symptom provocation in irritable bowel syndrome: relationship to enteric hypersensitivity and dysmotility","volume":"33","author":"Evans PR","year":"1998","unstructured":"Evans PR, Piesse C, Bak YT, Kellow JE. Fructose-sorbitol malabsorption and symptom provocation in irritable bowel syndrome: relationship to enteric hypersensitivity and dysmotility. Scand J Gastroenterol. 1998, 33:1158-63. 10.1080\/00365529850172502","journal-title":"Scand J Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/jhn.12144","article-title":"Dietary sorbitol and mannitol: food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome","volume":"27 Suppl 2","author":"Yao CK","year":"2014","unstructured":"Yao CK, Tan HL, van Langenberg DR, et al.. Dietary sorbitol and mannitol: food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome. J Hum Nutr Diet. 2014, 27 Suppl 2:263-75. 10.1111\/jhn.12144","journal-title":"J Hum Nutr Diet"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04018.x","article-title":"Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders","volume":"30","author":"Barrett JS","year":"2009","unstructured":"Barrett JS, Irving PM, Shepherd SJ, Muir JG, Gibson PR. Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders. Aliment Pharmacol Ther. 2009, 30:165-74. 10.1111\/j.1365-2036.2009.04018.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/nu12113368","article-title":"Low fermentable oligo- di- and mono-saccharides and polyols (FODMAPs) or gluten free diet: what is best for irritable bowel syndrome?","volume":"12","author":"Bellini M","year":"2020","unstructured":"Bellini M, Tonarelli S, Mumolo MG, et al.. Low fermentable oligo- di- and mono-saccharides and polyols (FODMAPs) or gluten free diet: what is best for irritable bowel syndrome?. Nutrients. 2020, 12:10.3390\/nu12113368","journal-title":"Nutrients"},{"key":"ref32","article-title":"The complete low-FODMAP diet: a revolutionary plan for managing IBS and other digestive disorders","author":"Shepherd S","year":"2013","unstructured":"Shepherd S, Gibson P. The complete low-FODMAP diet: a revolutionary plan for managing IBS and other digestive disorders. The Experiment, 2013."},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/nu12010148","article-title":"Low FODMAP diet: evidence, doubts, and hopes","volume":"12","author":"Bellini M","year":"2020","unstructured":"Bellini M, Tonarelli S, Nagy AG, et al.. Low FODMAP diet: evidence, doubts, and hopes. Nutrients. 2020, 12:10.3390\/nu12010148","journal-title":"Nutrients"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3945\/jn.112.159285","article-title":"Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome","volume":"142","author":"Staudacher HM","year":"2012","unstructured":"Staudacher HM, Lomer MC, Anderson JL, Barrett JS, Muir JG, Irving PM, Whelan K. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 2012, 142:1510-8. 10.3945\/jn.112.159285","journal-title":"J Nutr"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307264","article-title":"Diets that differ in their FODMAP content alter the colonic luminal microenvironment","volume":"64","author":"Halmos EP","year":"2015","unstructured":"Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Gibson PR, Muir JG. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut. 2015, 64:93-100. 10.1136\/gutjnl-2014-307264","journal-title":"Gut"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311339","article-title":"FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial","volume":"66","author":"McIntosh K","year":"2017","unstructured":"McIntosh K, Reed DE, Schneider T, et al.. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut. 2017, 66:1241-51. 10.1136\/gutjnl-2015-311339","journal-title":"Gut"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.487","article-title":"Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial","volume":"106","author":"Biesiekierski JR","year":"2011","unstructured":"Biesiekierski JR, Newnham ED, Irving PM, et al.. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol. 2011, 106:508-14; quiz 515. 10.1038\/ajg.2010.487","journal-title":"Am J Gastroenterol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.632312","article-title":"Western diet consumption during development: setting the stage for neurocognitive dysfunction","volume":"15","author":"Tsan L","year":"2021","unstructured":"Tsan L, D\u00e9carie-Spain L, Noble EE, Kanoski SE. Western diet consumption during development: setting the stage for neurocognitive dysfunction. Front Neurosci. 2021, 15:632312. 10.3389\/fnins.2021.632312","journal-title":"Front Neurosci"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-020-02439-5","article-title":"Glucose transporters in the small intestine in health and disease","volume":"472","author":"Koepsell H","year":"2020","unstructured":"Koepsell H. Glucose transporters in the small intestine in health and disease. Pflugers Arch. 2020, 472:1207-48. 10.1007\/s00424-020-02439-5","journal-title":"Pflugers Arch"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/nu12103129","article-title":"Identification of inflammatory and disease-associated plasma proteins that associate with intake of added sugar and sugar-sweetened beverages and their role in type 2 diabetes risk","volume":"12","author":"Ramne S","year":"2020","unstructured":"Ramne S, Drake I, Ericson U, Nilsson J, Orho-Melander M, Engstr\u00f6m G, Sonestedt E. Identification of inflammatory and disease-associated plasma proteins that associate with intake of added sugar and sugar-sweetened beverages and their role in type 2 diabetes risk. Nutrients. 2020, 12:10.3390\/nu12103129","journal-title":"Nutrients"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3402\/fnr.v60.32594","article-title":"An Okinawan-based Nordic diet improves anthropometry, metabolic control, and health-related quality of life in Scandinavian patients with type 2 diabetes: a pilot trial","volume":"60","author":"Darwiche G","year":"2016","unstructured":"Darwiche G, H\u00f6glund P, Roth B, et al.. An Okinawan-based Nordic diet improves anthropometry, metabolic control, and health-related quality of life in Scandinavian patients with type 2 diabetes: a pilot trial. Food Nutr Res. 2016, 60:32594. 10.3402\/fnr.v60.32594","journal-title":"Food Nutr Res"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3390\/nu13020416","article-title":"Assessment of a 4-week starch- and sucrose-reduced diet and its effects on gastrointestinal symptoms and inflammatory parameters among patients with irritable bowel syndrome","volume":"13","author":"Nilholm C","year":"2021","unstructured":"Nilholm C, Larsson E, Sonestedt E, Roth B, Ohlsson B. Assessment of a 4-week starch- and sucrose-reduced diet and its effects on gastrointestinal symptoms and inflammatory parameters among patients with irritable bowel syndrome. Nutrients. 2021, 13:10.3390\/nu13020416","journal-title":"Nutrients"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3390\/nu11061279","article-title":"Irregular dietary habits with a high intake of cereals and sweets are associated with more severe gastrointestinal symptoms in IBS patients","volume":"11","author":"Nilholm C","year":"2019","unstructured":"Nilholm C, Larsson E, Roth B, Gustafsson R, Ohlsson B. Irregular dietary habits with a high intake of cereals and sweets are associated with more severe gastrointestinal symptoms in IBS patients. Nutrients. 2019, 11:10.3390\/nu11061279","journal-title":"Nutrients"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.nutres.2020.12.001","article-title":"A carbohydrate-restricted diet for patients with irritable bowel syndrome lowers serum C-peptide, insulin, and leptin without any correlation with symptom reduction","volume":"86","author":"Saidi K","year":"2021","unstructured":"Saidi K, Nilholm C, Roth B, Ohlsson B. A carbohydrate-restricted diet for patients with irritable bowel syndrome lowers serum C-peptide, insulin, and leptin without any correlation with symptom reduction. Nutr Res. 2021, 86:23-36. 10.1016\/j.nutres.2020.12.001","journal-title":"Nutr Res"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12372","article-title":"Theories behind the effect of starch\u2011 and sucrose\u2011reduced diets on gastrointestinal symptoms in irritable bowel syndrome (review)","author":"Ohlsson B","year":"2021","unstructured":"Ohlsson B. Theories behind the effect of starch\u2011 and sucrose\u2011reduced diets on gastrointestinal symptoms in irritable bowel syndrome (review). Mol Med Rep. 2021, 10.3892\/mmr.2021.12372","journal-title":"Mol Med Rep"},{"key":"ref46","article-title":"Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria","volume":"5","author":"Hotel ACP","year":"2001","unstructured":"Hotel ACP, Cordoba A. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Prevention. 2001, 5:1-10.","journal-title":"Prevention"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.4315\/0362-028x-69.7.1675","article-title":"Adhesion properties and competitive pathogen exclusion ability of bifidobacteria with acquired acid resistance","volume":"69","author":"Collado MC","year":"2006","unstructured":"Collado MC, Gueimonde M, Sanz Y, Salminen S. Adhesion properties and competitive pathogen exclusion ability of bifidobacteria with acquired acid resistance. J Food Prot. 2006, 69:1675-9. 10.4315\/0362-028x-69.7.1675","journal-title":"J Food Prot"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00445","article-title":"The role of probiotics and prebiotics in inducing gut immunity","volume":"4","author":"Vieira AT","year":"2013","unstructured":"Vieira AT, Teixeira MM, Martins FS. The role of probiotics and prebiotics in inducing gut immunity. Front Immunol. 2013, 4:445. 10.3389\/fimmu.2013.00445","journal-title":"Front Immunol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12544","article-title":"Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial","volume":"27","author":"Choi CH","year":"2015","unstructured":"Choi CH, Kwon JG, Kim SK, et al.. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial. Neurogastroenterol Motil. 2015, 27:705-16. 10.1111\/nmo.12544","journal-title":"Neurogastroenterol Motil"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2018.1447380","article-title":"Fecal microbiota transplantation for managing irritable bowel syndrome","volume":"12","author":"El-Salhy M","year":"2018","unstructured":"El-Salhy M, Mazzawi T. Fecal microbiota transplantation for managing irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2018, 12:439-45. 10.1080\/17474124.2018.1447380","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2013.10.002","article-title":"Probiotics, gut microbiota and health","volume":"44","author":"Butel MJ","year":"2014","unstructured":"Butel MJ. Probiotics, gut microbiota and health. Med Mal Infect. 2014, 44:1-8. 10.1016\/j.medmal.2013.10.002","journal-title":"Med Mal Infect"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson GR","year":"2017","unstructured":"Gibson GR, Hutkins R, Sanders ME, et al.. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017, 14:491-502. 10.1038\/nrgastro.2017.75","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13080","article-title":"Colonic gas homeostasis: mechanisms of adaptation following HOST-G904 galactooligosaccharide use in humans","volume":"29","author":"Mego M","year":"2017","unstructured":"Mego M, Accarino A, Tzortzis G, Vulevic J, Gibson G, Guarner F, Azpiroz F. Colonic gas homeostasis: mechanisms of adaptation following HOST-G904 galactooligosaccharide use in humans. Neurogastroenterol Motil. 2017, 29:10.1111\/nmo.13080","journal-title":"Neurogastroenterol Motil"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.06.045","article-title":"Effects of prebiotics vs a diet low in FODMAPs in patients with functional gut disorders","volume":"155","author":"Huaman JW","year":"2018","unstructured":"Huaman JW, Mego M, Manichanh C, et al.. Effects of prebiotics vs a diet low in FODMAPs in patients with functional gut disorders. Gastroenterology. 2018, 155:1004-7. 10.1053\/j.gastro.2018.06.045","journal-title":"Gastroenterology"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0344-2","article-title":"The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics","volume":"17","author":"Swanson KS","year":"2020","unstructured":"Swanson KS, Gibson GR, Hutkins R, et al.. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol. 2020, 17:687-701. 10.1038\/s41575-020-0344-2","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/125.6.1401","article-title":"Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics","volume":"125","author":"Gibson GR","year":"1995","unstructured":"Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995, 125:1401-12. 10.1093\/jn\/125.6.1401","journal-title":"J Nutr"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-food-022510-133739","article-title":"Synbiotics in health and disease","volume":"2","author":"Kolida S","year":"2011","unstructured":"Kolida S, Gibson GR. Synbiotics in health and disease. Annu Rev Food Sci Technol. 2011, 2:373-93. 10.1146\/annurev-food-022510-133739","journal-title":"Annu Rev Food Sci Technol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13513","article-title":"Probiotics in irritable bowel syndrome: where are we?","volume":"30","author":"Barbara G","year":"2018","unstructured":"Barbara G, Cremon C, Azpiroz F. Probiotics in irritable bowel syndrome: where are we?. Neurogastroenterol Motil. 2018, 30:e13513. 10.1111\/nmo.13513","journal-title":"Neurogastroenterol Motil"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1177\/2050640617736478","article-title":"Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: a pilot randomized clinical trial","volume":"6","author":"Cremon C","year":"2018","unstructured":"Cremon C, Guglielmetti S, Gargari G, et al.. Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: a pilot randomized clinical trial. United European Gastroenterol J. 2018, 6:604-13. 10.1177\/2050640617736478","journal-title":"United European Gastroenterol J"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0084-x","article-title":"American College of Gastroenterology monograph on management of irritable bowel syndrome","volume":"113","author":"Ford AC","year":"2018","unstructured":"Ford AC, Moayyedi P, Chey WD, Harris LA, Lacy BE, Saito YA, Quigley EM. American College of Gastroenterology monograph on management of irritable bowel syndrome. Am J Gastroenterol. 2018, 113:1-18. 10.1038\/s41395-018-0084-x","journal-title":"Am J Gastroenterol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15001","article-title":"Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome","volume":"48","author":"Ford AC","year":"2018","unstructured":"Ford AC, Harris LA, Lacy BE, Quigley EM, Moayyedi P. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther. 2018, 48:1044-60. 10.1111\/apt.15001","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/166030-digesting-the-impact-of-diet-on-irritable-bowel-syndrome-ibs-exploring-solutions-for-controlling-ibs","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:53Z","timestamp":1707509093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/166030-digesting-the-impact-of-diet-on-irritable-bowel-syndrome-ibs-exploring-solutions-for-controlling-ibs"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":61,"URL":"https:\/\/doi.org\/10.7759\/cureus.45279","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,15]]}}}